These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27187183)

  • 1. Penile ulcers complicating systemic AL amyloidosis: a case report.
    Arun M; Sloan SB; Shelton A; Sanchorawala V
    Amyloid; 2016 Sep; 23(3):203-204. PubMed ID: 27187183
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.
    Kristen AV; Rosenberg M; Lindenmaier D; Merkle C; Steen H; Andre F; Schönland SO; Schnabel PA; Schuster T; Röcken C; Giannitsis E; Katus HA; Frey N
    Amyloid; 2014 Sep; 21(3):202-10. PubMed ID: 25007036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose melphalan followed by autologous stem cell support in primary systemic AL amyloidosis with multiple organ involvement.
    Shimojima Y; Matsuda M; Ishii W; Koyama J; Yamamoto K; Shimodaira S; Sakashita K; Koike K; Ikeda S
    Intern Med; 2005 May; 44(5):484-9. PubMed ID: 15942100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac amyloidosis: a practical approach to diagnosis and management.
    Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
    Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic amyloidosis presenting with glans penis involvement.
    Fernandez-Flores A; Castañón-González JA; Guerrero-Ramos B; Castro-Gaytan A; Saeb-Lima M
    J Cutan Pathol; 2014 Oct; 41(10):791-6. PubMed ID: 25093941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac amyloidosis].
    Hoyer C; Angermann CE; Knop S; Ertl G; Störk S
    Med Klin (Munich); 2008 Mar; 103(3):153-60. PubMed ID: 18344065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding and recognizing cardiac amyloidosis.
    McVeigh T; Tennyson C
    JAAPA; 2020 Oct; 33(10):16-20. PubMed ID: 32941304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AL amyloidosis manifesting as systemic lymphadenopathy.
    Matsuda M; Gono T; Shimojima Y; Yoshida T; Katoh N; Hoshii Y; Yamada T; Ikeda S
    Amyloid; 2008 Jun; 15(2):117-24. PubMed ID: 18484338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of amyloidosis].
    Wien TN
    Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1397-400. PubMed ID: 18552901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current treatment of AL amyloidosis].
    Kovacsovics T
    Rev Med Suisse Romande; 2000 Oct; 120(10):771-5. PubMed ID: 11109905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous PBSCT in patients with cardiac amyloidosis.
    Stevens JM; Patton WN; Heaton DC; Spearing RL; Shaw G; Bowie D; Smyth D; Comenzo R
    Bone Marrow Transplant; 2000 Sep; 26(5):588-9. PubMed ID: 11019855
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tenth International Symposium on Amyloid and Amyloidosis].
    Magy N; Grateau G
    Rev Med Interne; 2005 Feb; 26(2):167-71. PubMed ID: 15770789
    [No Abstract]   [Full Text] [Related]  

  • 14. Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients.
    Mignot A; Varnous S; Redonnet M; Jaccard A; Epailly E; Vermes E; Boissonnat P; Gandjbakhch I; Herpin D; Touchard G; Bridoux F
    Arch Cardiovasc Dis; 2008 Sep; 101(9):523-32. PubMed ID: 19041836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An atypical case of cardiac amyloidosis].
    Giannoni A; Aquaro DG; Masi L; Benedetti E; Cecconi N; Passino C; Emdin M
    Recenti Prog Med; 2009 May; 100(5):247-52. PubMed ID: 19772215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and long-term outcome of patients with systemic immunoglobulin light-chain amyloidosis.
    Nelson LM; Gustafsson F; Gimsing P
    Acta Haematol; 2015; 133(4):336-46. PubMed ID: 25531398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
    Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
    Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of primary amyloidosis].
    Ardashev VN; Potekhin NP; Rukavitsyn OA; Borisov AG; Malysheva SA
    Klin Med (Mosk); 2006; 84(6):56-9. PubMed ID: 16875072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
    Comenzo RL
    Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked and rapid regression of hepatic amyloid deposition in a patient with systemic light chain (AL) amyloidosis after high-dose melphalan therapy with stem cell transplantation.
    Katoh N; Matsushima A; Kurozumi M; Matsuda M; Ikeda S
    Intern Med; 2014; 53(17):1991-5. PubMed ID: 25175136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.